Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
Status:
Completed
Trial end date:
2020-06-15
Target enrollment:
Participant gender:
Summary
This is an open-label therapeutic efficacy study of Tirosint (levothyroxine sodium) capsules
in thyroidectomized patients taking proton pump inhibitors and levothyroxine, evaluating
changes in serum levels of TSH upon switch to Tirosint with respect to baseline.